British drugs firm Shire has said it expects to double its current product sales to $10bn by 2020 as it tries to fend off a $46bn (£27bn) bid from US rival AbbVie.
from BBC News - US & Canada http://ift.tt/1j6KjhW
via IFTTT
from BBC News - US & Canada http://ift.tt/1j6KjhW
via IFTTT